Cytokinetics (CYTK) Convertible Debt (2019 - 2026)
Cytokinetics (CYTK) reported Convertible Debt of $871.53 million for Q2 2026, up 57.3% from $553.99 million a year earlier and up 0.1% from the prior quarter.
Powered by 
Analysis
Cytokinetics (CYTK) Convertible Debt (2019 - 2026) Analysis & Trends
At the end of FY2025, Cytokinetics posted Convertible Debt of $869.6 million, up 57.4% from FY2024.
- Convertible Debt has increased for six consecutive years, with a five-year compound annual growth rate of 57.6% (FY2020 to FY2025).
- By year, Convertible Debt came in at $552.37 million in FY2024 (+0.6%), $548.99 million in FY2023 (+0.6%), $545.81 million in FY2022 (+471.7%) and $95.47 million in FY2021 (+6.7%).
- Five-year quarterly Convertible Debt spans a low of $93.89 million in Q3 2021 and a high of $889.52 million in Q3 2025.
- Year over year, Convertible Debt has now increased in each of the last 20 quarters, with growth averaging 29.5% over the last eight quarters.
- Across the past five years, year-over-year growth in Convertible Debt ran from 0.6% in Q3 2023 to 480.5% in Q3 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at $870.51 million (Q1 2026), $869.6 million (Q4 2025) and $889.52 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Cytokinetics | 9.20 Bn | 5.37 Bn | 25.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 871.53 Mn |
| Mar 31, 2026 | 870.51 Mn |
| Dec 31, 2025 | 869.60 Mn |
| Sep 30, 2025 | 889.52 Mn |
| Jun 30, 2025 | 553.99 Mn |
| Mar 31, 2025 | 553.14 Mn |
| Dec 31, 2024 | 552.37 Mn |
| Sep 30, 2024 | 551.48 Mn |
| Jun 30, 2024 | 550.60 Mn |
| Mar 31, 2024 | 549.79 Mn |
| Dec 31, 2023 | 548.99 Mn |
| Sep 30, 2023 | 548.13 Mn |
| Jun 30, 2023 | 547.29 Mn |
| Mar 31, 2023 | 546.51 Mn |
| Dec 31, 2022 | 545.81 Mn |
| Sep 30, 2022 | 544.99 Mn |
| Jun 30, 2022 | 134.67 Mn |
| Mar 31, 2022 | 134.51 Mn |
| Dec 31, 2021 | 95.47 Mn |
| Sep 30, 2021 | 93.89 Mn |
API Access
Cytokinetics Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=CYTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();